Highlights
NASDAQ: IDXG       Interpace Diag Grp
Last Price Today's Change   Day's Range   Trading Volume
0.86   +0.003 (0.35%)  0.85 - 0.89  305,100

Overview

 
Avg Volume (4 weeks):305,514
4 Weeks Range:0.767 - 0.99
4 Weeks Price Volatility (%):
41.70%
52 Weeks Range:0.72 - 2.05
52 Weeks Price Volatility (%):
10.53%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for patient diagnosis and management. The company currently has three commercialized molecular tests PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay.

  Be the first to like this.
 


 

4922  2695  853  90 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 14.18-1.11 
 NVCN 0.04+0.004 
 BAC 30.44-0.45 
 EEM 46.49-0.02 
 CHK 4.64+0.10 
 SPY 273.36+0.75 
 MU 59.97+0.94 
 HPE 15.58-1.83 
 AVGR 2.23+0.94 
 XLF 28.16-0.18 
Partners & Brokers